Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis

Journal of Alzheimer's Disease

Volumn 3, Issue 4, 2001, Pages 377-385

  Ranganathan, S ^a   Scudiere, S ^a   Bowser, R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Cell cycle; E2F 1; Retinoblastoma protein; Transcription factor

Indexed keywords

GENE PRODUCT; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NERVE CELL NECROSIS; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034849106     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3403     Document Type: Article

References (63)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
2. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease
3. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
4. Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells
5. Cyclin dependent kinase-5 (CDK5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS
6. Is apoptosis key in Alzheimer's disease?
7. Aging, energy, and oxidative stress in neurodegenerative diseases
8. Regulation of E2F: A family of transcription factors involved in proliferation control
9. Neuropathological stageing of Alzheimer-related changes
10. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
11. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles
12. The E2F transcription factor is a cellular target for the RB protein
13. The T/E1A-binding domain of the retinoblastoma product can interact selectively wilh a sequence-specific DNA-binding protein
14. Pathology of motor system disorder
15. Expression profiles of multiple genes in single neurons of Alzheimer's disease
16. Clinical manifestations and diagnostic evaluation of patients with Alzheimer's disease
17. Apoptosis in the brain: Physiology and pathology
18. Functional roles of E2F in cell cycle regulation
19. The role of E2F in the mammalian cell cycle
20. E2F-1 functions in mice to promote apoptosis and suppress proliferation
21. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death
22. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
23. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in B-amyloid-induced neuronal death
24. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells mover through G1
25. Inhibition of E2F1 transactivation by direct binding of the retinoblastoma protein
26. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation
27. The induction of multiple cell cycle events precedes target-related neuronal death
28. Transcription factor E2F binds DNA as a heterodimer
29. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis
30. Changes of p53 in the brains of patients with Alzheimer's disease
31. Alteration of transcription factors NF-kB and STAT1 in Alzheimer's disease brains
32. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
33. Aberrant RNA processing in a neurodegenerative disease: The cause to absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
34. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease
35. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contributions of a programmed cell death mechanism
36. Cell and molecular neurobiology of presenilins: A role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease
37. Celullar signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease
38. Mechanisms of cell death in Alzheimer disease-immunopathology
39. Abnormal expression of the cell cycle regulators p16 and cdk4 in Alzheimer's disease
40. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease
41. Signal transduction abnormalities in Alzheimer's disease: Evidence of a pathogenic stimuli
42. II. Standardization of the neuropathological assessment of Alzheimer's disease
43. Glial cytokines in Alzheimer's disease: Review and pathogenic implications
44. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis
45. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage
46. Apoptosis and Alzheimer's disease
47. A suicide note from Alzheimer disease neurons?
48. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
49. The role of cell cycle-mediated events in Alzheimer's disease
50. Cell division and the nervous system: Regulating the cycle from neural differentiation to death
51. Biology of disease: Protein kinases and phosphorylation in neurologic disorders and cell death
52. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease
53. Alzheimer's disease: A central role for amyloid
54. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
55. Immunohistochemical evidence for apoptosis in Alzheimer's disease
56. Preclinical and subclinical events in motor neuron disease
57. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions
58. Mutation of E2F-1 suppresses apoptosis and inappropriate S-phase entry and extends survival of Rb-deficient mouse embryos
59. Mitotic mechanisms in Alzheimer's Disease?
60. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
61. The retinoblastoma protein and cell cycle control
62. p53 and E2F-1 cooperate to mediate apoptosis
63. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives